data_1n9u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n9u _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 106.613 -1.625 . . . . 4.7999999999999998 106.613 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.1 -24.87 28.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.121 0.568 . . . . 1.6799999999999999 110.14 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -146.17 121.82 10.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.76 -1.57 . . . . 2.98 106.76 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.77 152.9 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.619 -1.623 . . . . 1.49 106.619 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -137.85 139.34 26.15 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.803 -1.184 . . . . 0.20000000000000001 107.803 165.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 -20.52 30.18 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.888 1.726 . . . . 0.26000000000000001 111.691 164.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -171.75 117.36 0.4 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.437 -1.69 . . . . 3.3700000000000001 106.437 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.53 58.75 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 103.711 -2.699 . . . . 3.0600000000000001 103.711 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 C--O 1.247 0.928 0 N-CA-C 106.422 -1.695 . . . . 2.04 106.422 -177.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 7.3600000000000003 106.763 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 1.3300000000000001 109.946 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 3.3700000000000001 106.282 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 1.6100000000000001 106.293 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.26000000000000001 107.461 167.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.23000000000000001 111.478 164.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 3.3399999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 3.1600000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 2.7400000000000002 107.116 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 7.3600000000000003 106.763 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 1.3300000000000001 109.946 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 3.3700000000000001 106.282 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 1.6100000000000001 106.293 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.26000000000000001 107.461 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.23000000000000001 111.478 164.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 3.3399999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 3.1600000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 2.7400000000000002 107.116 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 107.067 -1.457 . . . . 4.5199999999999996 107.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.78 -25.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 110.134 -0.321 . . . . 1.4099999999999999 110.134 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -144.83 120.95 10.78 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.039 -1.097 . . . . 3.3199999999999998 108.039 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.85 151.93 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.475 -1.676 . . . . 1.6599999999999999 106.475 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -138.36 142.09 33.82 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 107.381 -1.34 . . . . 0.33000000000000002 107.381 164.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.54 -20.81 35.37 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.012 1.808 . . . . 0.22 111.415 163.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -171.72 119.3 0.44 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.025 -1.842 . . . . 2.9700000000000002 106.025 -166.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -151.55 64.97 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.229 -2.878 . . . . 3.1499999999999999 103.229 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 C--O 1.246 0.896 0 N-CA-C 106.72 -1.585 . . . . 1.96 106.72 -171.272 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 106.722 -1.584 . . . . 4.8899999999999997 106.722 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.21 -24.98 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 118.422 0.555 . . . . 1.77 110.485 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.01 120.13 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.278 -1.749 . . . . 3.3500000000000001 106.278 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.12 154.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.148 -1.797 . . . . 1.55 106.148 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.71 142.62 32.01 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.191 -1.411 . . . . 0.44 107.191 163.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.79 -20.18 30.29 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.095 1.863 . . . . 0.20999999999999999 111.609 163.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -171.89 117.86 0.4 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.743 -1.947 . . . . 3.3100000000000001 105.743 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -149.58 60.79 1.01 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.742 -2.688 . . . . 3.1800000000000002 103.742 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.246 0.919 0 N-CA-C 106.587 -1.634 . . . . 1.96 106.587 -172.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 107.491 -1.299 . . . . 5.1900000000000004 107.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.13 -26.21 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.63 0.772 . . . . 1.6599999999999999 110.534 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.96 121.15 10.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.431 -1.692 . . . . 3.04 106.431 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.86 153.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.711 -1.589 . . . . 1.6799999999999999 106.711 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.32 139.12 26.85 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 108.055 -1.091 . . . . 0.27000000000000002 108.055 164.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -21.12 30.9 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.032 1.821 . . . . 0.28000000000000003 111.54 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -171.07 118.93 0.49 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.086 -1.82 . . . . 3.0299999999999998 106.086 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.27 58.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 103.629 -2.73 . . . . 3.1400000000000001 103.629 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 106.922 -1.51 . . . . 2.2400000000000002 106.922 -176.555 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 107.682 -1.229 . . . . 4.25 107.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.7 -24.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.01 0.924 . . . . 1.71 110.785 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -144.86 118.97 9.42 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.629 -1.619 . . . . 3.3199999999999998 106.629 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.79 153.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.751 -1.574 . . . . 1.53 106.751 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -139.01 138.75 21.62 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.913 -1.143 . . . . 0.17999999999999999 107.913 165.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.33 -20.39 32.19 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.83 1.687 . . . . 0.16 111.537 165.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -172.11 119.21 0.41 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.138 -1.801 . . . . 3.0499999999999998 106.138 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -148.35 59.63 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 103.308 -2.849 . . . . 3.27 103.308 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.247 0.964 0 N-CA-C 106.433 -1.692 . . . . 2.0600000000000001 106.433 -178.03 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 107.521 -1.289 . . . . 4.2400000000000002 107.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.33 -27.09 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.314 0.646 . . . . 1.75 109.699 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.16 124.84 13.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.417 -1.327 . . . . 3.0299999999999998 107.417 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.72 152.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.078 1.751 . . . . 1.6200000000000001 106.649 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -138.53 140.84 29.19 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 107.305 -1.369 . . . . 0.17999999999999999 107.305 164.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.39 -20.77 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.94 1.76 . . . . 0.19 111.617 164.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -170.91 117.84 0.48 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.269 -1.752 . . . . 3.0600000000000001 106.269 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -151.1 65.66 0.9 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 103.337 -2.838 . . . . 3.2000000000000002 103.337 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.253 1.239 0 CA-C-O 115.843 -2.027 . . . . 2.3100000000000001 106.331 -174.47 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 106.579 -1.637 . . . . 3.5499999999999998 106.579 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.82 -19.95 13.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.072 0.549 . . . . 1.6799999999999999 109.87 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -147.66 132.5 18.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.676 -1.972 . . . . 3.3100000000000001 105.676 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.9 151.75 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.281 -1.748 . . . . 1.5800000000000001 106.281 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -135.91 137.66 25.82 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.46 -1.311 . . . . 0.19 107.46 166.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.02 -20.14 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.823 1.682 . . . . 0.20999999999999999 111.514 164.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -171.91 118.31 0.41 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.043 -1.836 . . . . 3.3999999999999999 106.043 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -147.94 64.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 103.219 -2.882 . . . . 3.1499999999999999 103.219 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.343 -1.725 . . . . 2.0299999999999998 106.343 -175.357 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 107.741 -1.207 . . . . 4.2999999999999998 107.741 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.8 -23.34 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 123.585 0.754 . . . . 1.75 110.266 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -144.87 128.09 16.73 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.082 -1.822 . . . . 3.0499999999999998 106.082 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.67 151.99 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.747 -1.575 . . . . 1.6399999999999999 106.747 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -136.55 139.12 28.46 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.968 -1.123 . . . . 0.20000000000000001 107.968 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.27 -21.45 31.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.123 1.882 . . . . 0.20000000000000001 111.472 163.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -170.43 119.85 0.58 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 106.143 -1.799 . . . . 3.0600000000000001 106.143 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -148.4 64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 102.907 -2.997 . . . . 3.1800000000000002 102.907 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.247 0.959 0 N-CA-C 106.589 -1.634 . . . . 2.1099999999999999 106.589 -173.356 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 . . . . . 0 C--O 1.224 -0.247 0 N-CA-C 108.249 -1.019 . . . . 4.2699999999999996 108.249 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.03 -26.25 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 123.867 0.867 . . . . 2.1099999999999999 109.493 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -144.58 133.6 22.7 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.118 -1.808 . . . . 3.0699999999999998 106.118 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.42 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.294 -1.743 . . . . 1.6299999999999999 106.294 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -136.77 137.62 23.98 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.199 -1.408 . . . . 0.29999999999999999 107.199 167.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.02 -20.33 33.76 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.604 1.536 . . . . 0.27000000000000002 111.436 164.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -171.77 118.8 0.43 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.159 -1.793 . . . . 3.04 106.159 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.56 63.9 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 103.302 -2.851 . . . . 3.2599999999999998 103.302 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.032 -1.937 . . . . 2.4100000000000001 106.267 -175.659 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 107.285 -1.376 . . . . 4.54 107.285 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.47 -26.56 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 122.887 0.475 . . . . 1.6299999999999999 110.682 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -144.54 116.05 8.11 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.718 -1.215 . . . . 3.1400000000000001 107.718 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.02 155.42 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 106.025 -1.842 . . . . 1.6799999999999999 106.025 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -140.02 140.04 22.96 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 107.072 -1.455 . . . . 0.20000000000000001 107.072 164.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.43 -21.08 35.54 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.73 1.62 . . . . 0.28999999999999998 111.368 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -171.48 120.14 0.48 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.734 -1.95 . . . . 3.0299999999999998 105.734 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -147.14 63.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.877 -3.009 . . . . 3.1299999999999999 102.877 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.294 -1.813 . . . . 2.7599999999999998 106.726 -175.545 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 106.535 -1.654 . . . . 4.9000000000000004 106.535 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.31 -18.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.962 0.505 . . . . 1.3400000000000001 110.169 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.18 125.6 11.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.474 -1.676 . . . . 3.0800000000000001 106.474 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.78 152.5 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.187 -1.783 . . . . 1.5600000000000001 106.187 173.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.42 138.7 25.46 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.19 -19.49 34.02 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.717 1.612 . . . . 0.17999999999999999 111.58 164.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -172.61 118.31 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.036 -1.839 . . . . 3.0800000000000001 106.036 -169.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -148.23 63.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 103.348 -2.834 . . . . 3.1299999999999999 103.348 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.246 0.914 0 N-CA-C 106.418 -1.697 . . . . 2.0299999999999998 106.418 -177.485 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 107.597 -1.261 . . . . 6.2199999999999998 107.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -73.23 -22.79 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.605 1.162 . . . . 1.51 109.538 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -145.88 132.76 20.14 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.914 -2.254 . . . . 3.0800000000000001 104.914 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.12 152.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 105.905 -1.887 . . . . 1.6799999999999999 105.905 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -136.1 138.69 28.1 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.625 -1.25 . . . . 0.19 107.625 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.51 -20.43 31.31 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.007 1.804 . . . . 0.20000000000000001 111.53 164.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -171.25 119.07 0.48 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.296 -1.742 . . . . 3.4700000000000002 106.296 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.6 58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.774 -2.676 . . . . 3.1499999999999999 103.774 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.253 1.275 0 CA-C-O 115.869 -2.015 . . . . 1.8899999999999999 106.399 -175.481 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 105.753 -1.944 . . . . 5.3200000000000003 105.753 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.4 t -76.69 -20.77 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.161 0.505 . . . . 1.3500000000000001 109.729 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.69 134.69 21.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.586 -2.005 . . . . 3.3199999999999998 105.586 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.17 151.18 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.156 -1.794 . . . . 1.55 106.156 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -136.12 138.49 27.53 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 107.776 -1.194 . . . . 0.17999999999999999 107.776 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.27 -20.75 32.04 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.981 1.787 . . . . 0.17000000000000001 111.594 164.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -171.72 117.2 0.4 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.132 -1.803 . . . . 3.0600000000000001 106.132 -170.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -148.61 66.81 1.06 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 103.769 -2.678 . . . . 3.0899999999999999 103.769 173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.158 -1.877 . . . . 1.96 106.364 -175.475 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 106.011 -1.848 . . . . 3.5699999999999998 106.011 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.99 -18.71 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.122 0.487 . . . . 1.6799999999999999 109.814 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.6 135.01 20.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.403 -2.073 . . . . 3.3100000000000001 105.403 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.23 152.69 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.957 -1.868 . . . . 1.6299999999999999 105.957 174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.99 139.41 26.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.428 -1.323 . . . . 0.17000000000000001 107.428 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 -20.68 31.12 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.919 1.746 . . . . 0.19 111.558 164.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -171.92 117.45 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.147 -1.797 . . . . 3.0 106.147 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -151.34 63.7 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 103.666 -2.716 . . . . 3.1099999999999999 103.666 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.183 0 CA-C-O 116.034 -1.936 . . . . 2.1600000000000001 105.965 -175.026 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 107.435 -1.32 . . . . 3.9399999999999999 107.435 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.23 -18.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 123.671 0.788 . . . . 1.6699999999999999 109.826 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.13 132.42 16.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.944 -1.873 . . . . 3.3399999999999999 105.944 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.52 151.62 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 106.47 -1.678 . . . . 1.6599999999999999 106.47 175.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -136.35 139.32 29.38 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.574 -1.269 . . . . 0.20999999999999999 107.574 166.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.26 -20.08 32.95 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.883 1.722 . . . . 0.20999999999999999 111.647 164.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -171.81 119.55 0.44 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.103 -1.814 . . . . 3.3300000000000001 106.103 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -153.46 61.79 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.226 -2.509 . . . . 3.1699999999999999 104.226 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.269 -1.752 . . . . 1.96 106.269 -170.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.776 -1.194 . . . . 4.3899999999999997 107.776 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.97 -25.19 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 123.015 0.526 . . . . 1.78 110.463 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -146.44 117.83 7.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.193 -1.41 . . . . 3.1099999999999999 107.193 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.54 152.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.545 -1.65 . . . . 1.5700000000000001 106.545 175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -138.22 138.59 23.26 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.446 -1.316 . . . . 0.20999999999999999 107.446 165.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.63 -19.39 32.05 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.773 1.649 . . . . 0.17999999999999999 111.647 165.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -172.14 119.22 0.41 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.092 -1.818 . . . . 3.0499999999999998 106.092 -169.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -149.75 57.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.761 -2.681 . . . . 3.1499999999999999 103.761 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.246 0.895 0 N-CA-C 106.573 -1.64 . . . . 1.97 106.573 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 106.471 -1.677 . . . . 3.7999999999999998 106.471 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.82 -23.23 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.077 0.465 . . . . 1.6599999999999999 110.02 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -143.81 132.7 22.69 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.148 -1.797 . . . . 3.1800000000000002 106.148 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.04 151.4 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 1.51 106.215 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.59 139.01 25.82 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.482 -1.303 . . . . 0.17999999999999999 107.482 166.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.2 -20.03 33.29 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.874 1.716 . . . . 0.23000000000000001 111.578 163.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -171.24 118.47 0.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.424 -1.695 . . . . 3.3900000000000001 106.424 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -150.37 63.29 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.2 -2.889 . . . . 3.2000000000000002 103.2 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.247 0.933 0 N-CA-C 106.447 -1.686 . . . . 2.1000000000000001 106.447 -174.555 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 . . . . . 0 C--O 1.223 -0.296 0 N-CA-C 108.869 -0.789 . . . . 4.3499999999999996 108.869 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.45 -24.14 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 124.952 1.301 . . . . 1.75 110.751 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -145.48 119.04 9.09 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.676 -1.601 . . . . 3.0499999999999998 106.676 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.53 153.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.418 -1.697 . . . . 1.5800000000000001 106.418 175.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -138.46 140.25 27.47 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.045 -1.465 . . . . 0.31 107.045 165.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.05 -20.96 32.8 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.559 1.506 . . . . 0.26000000000000001 111.325 164.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -170.95 115.71 0.44 Allowed 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.738 -1.579 . . . . 3.5699999999999998 106.738 -167.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -153.52 35.98 0.46 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.671 -1.603 . . . . 3.46 106.671 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 115.891 -2.004 . . . . 4.8399999999999999 107.186 -175.578 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.01 -24.77 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.473 0.579 . . . . 0.0 110.009 172.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.61 123.16 11.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.27 150.82 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -136.55 141.09 34.27 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 164.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.39 -21.48 30.49 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.283 1.989 . . . . 0.0 111.641 163.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -170.23 122.61 0.67 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 -167.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.61 59.7 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.064 -168.474 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.064 -0.717 . . . . 3.0499999999999998 109.064 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -144.52 118.56 9.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.613 -1.625 . . . . 4.7999999999999998 106.613 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.1 -24.87 28.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.121 0.568 . . . . 1.6799999999999999 110.14 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -146.17 121.82 10.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.76 -1.57 . . . . 2.98 106.76 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.77 152.9 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.619 -1.623 . . . . 1.49 106.619 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -137.85 139.34 26.15 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.803 -1.184 . . . . 0.20000000000000001 107.803 165.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 -20.52 30.18 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.888 1.726 . . . . 0.26000000000000001 111.691 164.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -171.75 117.36 0.4 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.437 -1.69 . . . . 3.3700000000000001 106.437 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.53 58.75 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 103.711 -2.699 . . . . 3.0600000000000001 103.711 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 C--O 1.247 0.928 0 N-CA-C 106.422 -1.695 . . . . 2.04 106.422 -177.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.157 -1.053 . . . . 3.6699999999999999 108.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -125.97 135.68 52.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 7.3600000000000003 106.763 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 1.3300000000000001 109.946 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 3.3700000000000001 106.282 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 1.6100000000000001 106.293 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.26000000000000001 107.461 167.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.23000000000000001 111.478 164.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 3.3399999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 3.1600000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 2.7400000000000002 107.116 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.157 -1.053 . . . . 3.6699999999999999 108.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -125.97 135.68 52.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 7.3600000000000003 106.763 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 1.3300000000000001 109.946 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 3.3700000000000001 106.282 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 1.6100000000000001 106.293 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.26000000000000001 107.461 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.23000000000000001 111.478 164.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 3.3399999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 3.1600000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 2.7400000000000002 107.116 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.047 -0.723 . . . . 4.8799999999999999 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -141.99 128.0 19.55 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.067 -1.457 . . . . 4.5199999999999996 107.067 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.78 -25.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 110.134 -0.321 . . . . 1.4099999999999999 110.134 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -144.83 120.95 10.78 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.039 -1.097 . . . . 3.3199999999999998 108.039 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.85 151.93 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.475 -1.676 . . . . 1.6599999999999999 106.475 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -138.36 142.09 33.82 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 107.381 -1.34 . . . . 0.33000000000000002 107.381 164.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.54 -20.81 35.37 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.012 1.808 . . . . 0.22 111.415 163.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -171.72 119.3 0.44 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.025 -1.842 . . . . 2.9700000000000002 106.025 -166.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -151.55 64.97 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.229 -2.878 . . . . 3.1499999999999999 103.229 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 C--O 1.246 0.896 0 N-CA-C 106.72 -1.585 . . . . 1.96 106.72 -171.272 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.964 -0.754 . . . . 3.46 108.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 122.01 9.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.722 -1.584 . . . . 4.8899999999999997 106.722 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.21 -24.98 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 118.422 0.555 . . . . 1.77 110.485 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.01 120.13 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.278 -1.749 . . . . 3.3500000000000001 106.278 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.12 154.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.148 -1.797 . . . . 1.55 106.148 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.71 142.62 32.01 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.191 -1.411 . . . . 0.44 107.191 163.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.79 -20.18 30.29 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.095 1.863 . . . . 0.20999999999999999 111.609 163.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -171.89 117.86 0.4 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.743 -1.947 . . . . 3.3100000000000001 105.743 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -149.58 60.79 1.01 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.742 -2.688 . . . . 3.1800000000000002 103.742 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.246 0.919 0 N-CA-C 106.587 -1.634 . . . . 1.96 106.587 -172.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 t0 . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 121.249 0.547 . . . . 4.54 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -148.45 125.94 11.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.476 -1.39 . . . . 5.1900000000000004 107.491 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.13 -26.21 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.63 0.772 . . . . 1.6599999999999999 110.534 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.96 121.15 10.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.431 -1.692 . . . . 3.04 106.431 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.86 153.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.711 -1.589 . . . . 1.6799999999999999 106.711 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.32 139.12 26.85 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 108.055 -1.091 . . . . 0.27000000000000002 108.055 164.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -21.12 30.9 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.032 1.821 . . . . 0.28000000000000003 111.54 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -171.07 118.93 0.49 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.086 -1.82 . . . . 3.0299999999999998 106.086 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.27 58.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 103.629 -2.73 . . . . 3.1400000000000001 103.629 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 106.922 -1.51 . . . . 2.2400000000000002 106.922 -176.555 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 3.0699999999999998 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -148.65 119.97 7.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.682 -1.229 . . . . 4.25 107.682 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.7 -24.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.01 0.924 . . . . 1.71 110.785 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -144.86 118.97 9.42 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.629 -1.619 . . . . 3.3199999999999998 106.629 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.79 153.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.751 -1.574 . . . . 1.53 106.751 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -139.01 138.75 21.62 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.913 -1.143 . . . . 0.17999999999999999 107.913 165.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.33 -20.39 32.19 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.83 1.687 . . . . 0.16 111.537 165.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -172.11 119.21 0.41 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.138 -1.801 . . . . 3.0499999999999998 106.138 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -148.35 59.63 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 103.308 -2.849 . . . . 3.27 103.308 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.247 0.964 0 N-CA-C 106.433 -1.692 . . . . 2.0600000000000001 106.433 -178.03 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 107.724 -1.213 . . . . 4.2300000000000004 107.724 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -138.8 117.24 12.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.521 -1.289 . . . . 4.2400000000000002 107.521 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.33 -27.09 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.314 0.646 . . . . 1.75 109.699 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.16 124.84 13.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.417 -1.327 . . . . 3.0299999999999998 107.417 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.72 152.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.078 1.751 . . . . 1.6200000000000001 106.649 175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -138.53 140.84 29.19 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 107.305 -1.369 . . . . 0.17999999999999999 107.305 164.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.39 -20.77 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.94 1.76 . . . . 0.19 111.617 164.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -170.91 117.84 0.48 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.269 -1.752 . . . . 3.0600000000000001 106.269 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -151.1 65.66 0.9 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 103.337 -2.838 . . . . 3.2000000000000002 103.337 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.253 1.239 0 CA-C-O 115.843 -2.027 . . . . 2.3100000000000001 106.331 -174.47 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 108.631 -0.878 . . . . 2.7999999999999998 108.631 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.2 131.53 26.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.579 -1.637 . . . . 3.5499999999999998 106.579 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.82 -19.95 13.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.072 0.549 . . . . 1.6799999999999999 109.87 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -147.66 132.5 18.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.676 -1.972 . . . . 3.3100000000000001 105.676 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.9 151.75 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.281 -1.748 . . . . 1.5800000000000001 106.281 175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -135.91 137.66 25.82 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.46 -1.311 . . . . 0.19 107.46 166.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.02 -20.14 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.823 1.682 . . . . 0.20999999999999999 111.514 164.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -171.91 118.31 0.41 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.043 -1.836 . . . . 3.3999999999999999 106.043 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -147.94 64.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 103.219 -2.882 . . . . 3.1499999999999999 103.219 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.343 -1.725 . . . . 2.0299999999999998 106.343 -175.357 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 108.147 -1.057 . . . . 3.6899999999999999 108.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.65 123.17 12.43 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.741 -1.207 . . . . 4.2999999999999998 107.741 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.8 -23.34 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 123.585 0.754 . . . . 1.75 110.266 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -144.87 128.09 16.73 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.082 -1.822 . . . . 3.0499999999999998 106.082 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -110.67 151.99 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.747 -1.575 . . . . 1.6399999999999999 106.747 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -136.55 139.12 28.46 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.968 -1.123 . . . . 0.20000000000000001 107.968 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.27 -21.45 31.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.123 1.882 . . . . 0.20000000000000001 111.472 163.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -170.43 119.85 0.58 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 106.143 -1.799 . . . . 3.0600000000000001 106.143 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -148.4 64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 102.907 -2.997 . . . . 3.1800000000000002 102.907 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.247 0.959 0 N-CA-C 106.589 -1.634 . . . . 2.1099999999999999 106.589 -173.356 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 t0 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 117.99 -1.005 . . . . 4.1399999999999997 108.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -130.02 119.57 23.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 120.004 1.274 . . . . 4.2699999999999996 108.249 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.03 -26.25 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 123.867 0.867 . . . . 2.1099999999999999 109.493 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -144.58 133.6 22.7 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.118 -1.808 . . . . 3.0699999999999998 106.118 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.42 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.294 -1.743 . . . . 1.6299999999999999 106.294 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -136.77 137.62 23.98 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.199 -1.408 . . . . 0.29999999999999999 107.199 167.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.02 -20.33 33.76 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.604 1.536 . . . . 0.27000000000000002 111.436 164.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -171.77 118.8 0.43 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.159 -1.793 . . . . 3.04 106.159 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.56 63.9 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 103.302 -2.851 . . . . 3.2599999999999998 103.302 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.032 -1.937 . . . . 2.4100000000000001 106.267 -175.659 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.775 -0.454 . . . . 3.75 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -134.15 120.35 19.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.285 -1.376 . . . . 4.54 107.285 -175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.47 -26.56 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 122.887 0.475 . . . . 1.6299999999999999 110.682 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -144.54 116.05 8.11 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.718 -1.215 . . . . 3.1400000000000001 107.718 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.02 155.42 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 106.025 -1.842 . . . . 1.6799999999999999 106.025 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -140.02 140.04 22.96 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 107.072 -1.455 . . . . 0.20000000000000001 107.072 164.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.43 -21.08 35.54 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.73 1.62 . . . . 0.28999999999999998 111.368 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -171.48 120.14 0.48 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.734 -1.95 . . . . 3.0299999999999998 105.734 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -147.14 63.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.877 -3.009 . . . . 3.1299999999999999 102.877 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.294 -1.813 . . . . 2.7599999999999998 106.726 -175.545 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 108.538 -0.912 . . . . 3.0800000000000001 108.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -140.24 130.12 24.64 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.535 -1.654 . . . . 4.9000000000000004 106.535 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.31 -18.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.962 0.505 . . . . 1.3400000000000001 110.169 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.18 125.6 11.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.474 -1.676 . . . . 3.0800000000000001 106.474 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.78 152.5 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.187 -1.783 . . . . 1.5600000000000001 106.187 173.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.42 138.7 25.46 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.19 -19.49 34.02 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.717 1.612 . . . . 0.17999999999999999 111.58 164.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -172.61 118.31 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.036 -1.839 . . . . 3.0800000000000001 106.036 -169.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -148.23 63.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 103.348 -2.834 . . . . 3.1299999999999999 103.348 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.246 0.914 0 N-CA-C 106.418 -1.697 . . . . 2.0299999999999998 106.418 -177.485 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.792 0.806 . . . . 4.21 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -139.73 123.09 17.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.597 -1.261 . . . . 6.2199999999999998 107.597 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -73.23 -22.79 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.605 1.162 . . . . 1.51 109.538 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -145.88 132.76 20.14 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.914 -2.254 . . . . 3.0800000000000001 104.914 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.12 152.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 105.905 -1.887 . . . . 1.6799999999999999 105.905 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -136.1 138.69 28.1 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.625 -1.25 . . . . 0.19 107.625 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.51 -20.43 31.31 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.007 1.804 . . . . 0.20000000000000001 111.53 164.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -171.25 119.07 0.48 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.296 -1.742 . . . . 3.4700000000000002 106.296 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.6 58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.774 -2.676 . . . . 3.1499999999999999 103.774 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.253 1.275 0 CA-C-O 115.869 -2.015 . . . . 1.8899999999999999 106.399 -175.481 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 2.7799999999999998 108.997 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.09 132.7 28.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.753 -1.944 . . . . 5.3200000000000003 105.753 166.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.4 t -76.69 -20.77 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.161 0.505 . . . . 1.3500000000000001 109.729 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.69 134.69 21.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.586 -2.005 . . . . 3.3199999999999998 105.586 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.17 151.18 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.156 -1.794 . . . . 1.55 106.156 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -136.12 138.49 27.53 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 107.776 -1.194 . . . . 0.17999999999999999 107.776 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.27 -20.75 32.04 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.981 1.787 . . . . 0.17000000000000001 111.594 164.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -171.72 117.2 0.4 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.132 -1.803 . . . . 3.0600000000000001 106.132 -170.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -148.61 66.81 1.06 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 103.769 -2.678 . . . . 3.0899999999999999 103.769 173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.158 -1.877 . . . . 1.96 106.364 -175.475 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.216 -0.661 . . . . 3.2200000000000002 109.216 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.35 131.09 27.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.011 -1.848 . . . . 3.5699999999999998 106.011 169.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.99 -18.71 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.122 0.487 . . . . 1.6799999999999999 109.814 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.6 135.01 20.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.403 -2.073 . . . . 3.3100000000000001 105.403 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.23 152.69 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.957 -1.868 . . . . 1.6299999999999999 105.957 174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.99 139.41 26.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.428 -1.323 . . . . 0.17000000000000001 107.428 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 -20.68 31.12 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.919 1.746 . . . . 0.19 111.558 164.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -171.92 117.45 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.147 -1.797 . . . . 3.0 106.147 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -151.34 63.7 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 103.666 -2.716 . . . . 3.1099999999999999 103.666 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.183 0 CA-C-O 116.034 -1.936 . . . . 2.1600000000000001 105.965 -175.026 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.174 -0.676 . . . . 3.2999999999999998 109.174 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -137.48 136.71 37.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.435 -1.32 . . . . 3.9399999999999999 107.435 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.23 -18.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 123.671 0.788 . . . . 1.6699999999999999 109.826 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.13 132.42 16.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.944 -1.873 . . . . 3.3399999999999999 105.944 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.52 151.62 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 106.47 -1.678 . . . . 1.6599999999999999 106.47 175.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -136.35 139.32 29.38 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.574 -1.269 . . . . 0.20999999999999999 107.574 166.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.26 -20.08 32.95 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.883 1.722 . . . . 0.20999999999999999 111.647 164.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -171.81 119.55 0.44 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.103 -1.814 . . . . 3.3300000000000001 106.103 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -153.46 61.79 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.226 -2.509 . . . . 3.1699999999999999 104.226 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.269 -1.752 . . . . 1.96 106.269 -170.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 108.365 -0.976 . . . . 3.8399999999999999 108.365 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 121.11 18.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.776 -1.194 . . . . 4.3899999999999997 107.776 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.97 -25.19 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 123.015 0.526 . . . . 1.78 110.463 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -146.44 117.83 7.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.193 -1.41 . . . . 3.1099999999999999 107.193 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.54 152.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.545 -1.65 . . . . 1.5700000000000001 106.545 175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -138.22 138.59 23.26 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.446 -1.316 . . . . 0.20999999999999999 107.446 165.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.63 -19.39 32.05 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.773 1.649 . . . . 0.17999999999999999 111.647 165.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -172.14 119.22 0.41 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.092 -1.818 . . . . 3.0499999999999998 106.092 -169.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -149.75 57.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.761 -2.681 . . . . 3.1499999999999999 103.761 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.246 0.895 0 N-CA-C 106.573 -1.64 . . . . 1.97 106.573 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.164 -0.68 . . . . 3.3399999999999999 109.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -142.96 124.37 14.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.471 -1.677 . . . . 3.7999999999999998 106.471 175.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.82 -23.23 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.077 0.465 . . . . 1.6599999999999999 110.02 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -143.81 132.7 22.69 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.148 -1.797 . . . . 3.1800000000000002 106.148 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.04 151.4 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 1.51 106.215 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.59 139.01 25.82 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.482 -1.303 . . . . 0.17999999999999999 107.482 166.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.2 -20.03 33.29 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.874 1.716 . . . . 0.23000000000000001 111.578 163.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -171.24 118.47 0.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.424 -1.695 . . . . 3.3900000000000001 106.424 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -150.37 63.29 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.2 -2.889 . . . . 3.2000000000000002 103.2 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.247 0.933 0 N-CA-C 106.447 -1.686 . . . . 2.1000000000000001 106.447 -174.555 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.4 t0 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 117.51 -1.233 . . . . 4.2999999999999998 107.943 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 -135.55 116.21 13.89 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 120.671 1.578 . . . . 4.3499999999999996 108.869 -172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.45 -24.14 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 124.952 1.301 . . . . 1.75 110.751 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -145.48 119.04 9.09 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.676 -1.601 . . . . 3.0499999999999998 106.676 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.53 153.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.418 -1.697 . . . . 1.5800000000000001 106.418 175.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -138.46 140.25 27.47 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.045 -1.465 . . . . 0.31 107.045 165.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.05 -20.96 32.8 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.559 1.506 . . . . 0.26000000000000001 111.325 164.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -170.95 115.71 0.44 Allowed 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.738 -1.579 . . . . 3.5699999999999998 106.738 -167.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -153.52 35.98 0.46 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.671 -1.603 . . . . 3.46 106.671 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 115.891 -2.004 . . . . 4.8399999999999999 107.186 -175.578 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.13 129.72 18.0 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 172.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.01 -24.77 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.473 0.579 . . . . 0.0 110.009 172.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.61 123.16 11.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.27 150.82 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -136.55 141.09 34.27 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 164.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.39 -21.48 30.49 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.283 1.989 . . . . 0.0 111.641 163.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -170.23 122.61 0.67 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 -167.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.61 59.7 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.064 -168.474 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 106.613 -1.625 . . . . 3.8300000000000001 106.613 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.1 -24.87 28.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.121 0.568 . . . . 0.25 110.14 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -146.17 121.82 10.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.76 -1.57 . . . . 1.6899999999999999 106.76 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -105.77 152.9 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.619 -1.623 . . . . 0.20000000000000001 106.619 175.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -137.85 139.34 26.15 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.803 -1.184 . . . . 0.20000000000000001 107.803 165.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 -20.52 30.18 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.888 1.726 . . . . 0.19 111.691 164.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -171.75 117.36 0.4 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.437 -1.69 . . . . 1.9399999999999999 106.437 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.53 58.75 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 103.711 -2.699 . . . . 1.6799999999999999 103.711 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 C--O 1.247 0.928 0 N-CA-C 106.422 -1.695 . . . . 1.4099999999999999 106.422 -177.077 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 107.067 -1.457 . . . . 3.5899999999999999 107.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.78 -25.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 110.134 -0.321 . . . . 0.29999999999999999 110.134 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -144.83 120.95 10.78 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.039 -1.097 . . . . 1.8799999999999999 108.039 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.85 151.93 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.475 -1.676 . . . . 0.17999999999999999 106.475 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -138.36 142.09 33.82 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 107.381 -1.34 . . . . 0.32000000000000001 107.381 164.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.54 -20.81 35.37 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.012 1.808 . . . . 0.19 111.415 163.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -171.72 119.3 0.44 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.025 -1.842 . . . . 1.6899999999999999 106.025 -166.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -151.55 64.97 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.229 -2.878 . . . . 1.79 103.229 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 C--O 1.246 0.896 0 N-CA-C 106.72 -1.585 . . . . 1.4299999999999999 106.72 -171.272 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 106.722 -1.584 . . . . 4.0899999999999999 106.722 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.21 -24.98 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 118.422 0.555 . . . . 0.28999999999999998 110.485 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.01 120.13 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.278 -1.749 . . . . 1.8999999999999999 106.278 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.12 154.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.148 -1.797 . . . . 0.19 106.148 176.224 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.71 142.62 32.01 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.191 -1.411 . . . . 0.42999999999999999 107.191 163.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.79 -20.18 30.29 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.095 1.863 . . . . 0.17999999999999999 111.609 163.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -171.89 117.86 0.4 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.743 -1.947 . . . . 1.8799999999999999 105.743 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -149.58 60.79 1.01 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.742 -2.688 . . . . 1.8300000000000001 103.742 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.246 0.919 0 N-CA-C 106.587 -1.634 . . . . 1.4399999999999999 106.587 -172.815 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 107.491 -1.299 . . . . 4.3700000000000001 107.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.13 -26.21 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.63 0.772 . . . . 0.22 110.534 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.96 121.15 10.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.431 -1.692 . . . . 1.75 106.431 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -103.86 153.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.711 -1.589 . . . . 0.23000000000000001 106.711 176.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.32 139.12 26.85 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 108.055 -1.091 . . . . 0.25 108.055 164.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -21.12 30.9 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.032 1.821 . . . . 0.25 111.54 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -171.07 118.93 0.49 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.086 -1.82 . . . . 1.73 106.086 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.27 58.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 103.629 -2.73 . . . . 1.8 103.629 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 106.922 -1.51 . . . . 1.5700000000000001 106.922 -176.555 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 107.682 -1.229 . . . . 3.3900000000000001 107.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.7 -24.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.01 0.924 . . . . 0.25 110.785 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -144.86 118.97 9.42 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.629 -1.619 . . . . 1.8899999999999999 106.629 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -101.79 153.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.751 -1.574 . . . . 0.17999999999999999 106.751 176.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -139.01 138.75 21.62 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.913 -1.143 . . . . 0.17000000000000001 107.913 165.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.33 -20.39 32.19 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.83 1.687 . . . . 0.14000000000000001 111.537 165.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -172.11 119.21 0.41 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.138 -1.801 . . . . 1.76 106.138 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -148.35 59.63 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 103.308 -2.849 . . . . 1.8999999999999999 103.308 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.247 0.964 0 N-CA-C 106.433 -1.692 . . . . 1.47 106.433 -178.03 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 107.521 -1.289 . . . . 3.3300000000000001 107.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.33 -27.09 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.314 0.646 . . . . 0.38 109.699 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.16 124.84 13.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.417 -1.327 . . . . 1.73 107.417 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -109.72 152.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.078 1.751 . . . . 0.14999999999999999 106.649 175.197 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -138.53 140.84 29.19 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 107.305 -1.369 . . . . 0.17999999999999999 107.305 164.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.39 -20.77 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.94 1.76 . . . . 0.17000000000000001 111.617 164.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -170.91 117.84 0.48 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.269 -1.752 . . . . 1.78 106.269 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -151.1 65.66 0.9 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 103.337 -2.838 . . . . 1.8700000000000001 103.337 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.253 1.239 0 CA-C-O 115.843 -2.027 . . . . 1.98 106.331 -174.47 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 106.579 -1.637 . . . . 2.9900000000000002 106.579 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.82 -19.95 13.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.072 0.549 . . . . 0.25 109.87 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -147.66 132.5 18.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.676 -1.972 . . . . 1.8700000000000001 105.676 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -116.9 151.75 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.281 -1.748 . . . . 0.19 106.281 175.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -135.91 137.66 25.82 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.46 -1.311 . . . . 0.19 107.46 166.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.02 -20.14 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.823 1.682 . . . . 0.17999999999999999 111.514 164.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -171.91 118.31 0.41 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.043 -1.836 . . . . 1.97 106.043 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -147.94 64.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 103.219 -2.882 . . . . 1.8100000000000001 103.219 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.343 -1.725 . . . . 1.46 106.343 -175.357 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 107.741 -1.207 . . . . 3.21 107.741 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.8 -23.34 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 123.585 0.754 . . . . 0.23999999999999999 110.266 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -144.87 128.09 16.73 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.082 -1.822 . . . . 1.74 106.082 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.67 151.99 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.747 -1.575 . . . . 0.26000000000000001 106.747 174.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -136.55 139.12 28.46 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.968 -1.123 . . . . 0.20000000000000001 107.968 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.27 -21.45 31.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.123 1.882 . . . . 0.16 111.472 163.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -170.43 119.85 0.58 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 106.143 -1.799 . . . . 1.77 106.143 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -148.4 64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 102.907 -2.997 . . . . 1.6699999999999999 102.907 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.247 0.959 0 N-CA-C 106.589 -1.634 . . . . 1.3999999999999999 106.589 -173.356 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 . . . . . 0 C--O 1.224 -0.247 0 N-CA-C 108.249 -1.019 . . . . 3.2000000000000002 108.249 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.03 -26.25 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 123.867 0.867 . . . . 0.46999999999999997 109.493 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -144.58 133.6 22.7 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.118 -1.808 . . . . 1.78 106.118 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.2 152.42 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.294 -1.743 . . . . 0.17999999999999999 106.294 175.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -136.77 137.62 23.98 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.199 -1.408 . . . . 0.28999999999999998 107.199 167.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.02 -20.33 33.76 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.604 1.536 . . . . 0.23999999999999999 111.436 164.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -171.77 118.8 0.43 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.159 -1.793 . . . . 1.75 106.159 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.56 63.9 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 103.302 -2.851 . . . . 1.9199999999999999 103.302 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.032 -1.937 . . . . 1.96 106.267 -175.659 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 107.285 -1.376 . . . . 3.5600000000000001 107.285 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.47 -26.56 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 122.887 0.475 . . . . 0.25 110.682 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -144.54 116.05 8.11 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.718 -1.215 . . . . 1.8200000000000001 107.718 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -98.02 155.42 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 106.025 -1.842 . . . . 0.23999999999999999 106.025 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -140.02 140.04 22.96 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 107.072 -1.455 . . . . 0.20000000000000001 107.072 164.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.43 -21.08 35.54 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.73 1.62 . . . . 0.22 111.368 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -171.48 120.14 0.48 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.734 -1.95 . . . . 1.74 105.734 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -147.14 63.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.877 -3.009 . . . . 1.6699999999999999 102.877 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.294 -1.813 . . . . 2.0099999999999998 106.726 -175.545 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 106.535 -1.654 . . . . 4.2300000000000004 106.535 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.31 -18.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.962 0.505 . . . . 0.20999999999999999 110.169 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.18 125.6 11.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.474 -1.676 . . . . 1.78 106.474 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -107.78 152.5 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.187 -1.783 . . . . 0.20999999999999999 106.187 173.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.42 138.7 25.46 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.19 -19.49 34.02 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.717 1.612 . . . . 0.16 111.58 164.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -172.61 118.31 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.036 -1.839 . . . . 1.79 106.036 -169.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -148.23 63.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 103.348 -2.834 . . . . 1.6499999999999999 103.348 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.246 0.914 0 N-CA-C 106.418 -1.697 . . . . 1.4199999999999999 106.418 -177.485 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 107.597 -1.261 . . . . 4.7800000000000002 107.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -73.23 -22.79 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.605 1.162 . . . . 0.39000000000000001 109.538 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -145.88 132.76 20.14 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.914 -2.254 . . . . 1.78 104.914 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -119.12 152.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 105.905 -1.887 . . . . 0.25 105.905 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -136.1 138.69 28.1 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.625 -1.25 . . . . 0.19 107.625 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.51 -20.43 31.31 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.007 1.804 . . . . 0.17999999999999999 111.53 164.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -171.25 119.07 0.48 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.296 -1.742 . . . . 2.0299999999999998 106.296 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.6 58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.774 -2.676 . . . . 1.8 103.774 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.253 1.275 0 CA-C-O 115.869 -2.015 . . . . 1.8899999999999999 106.399 -175.481 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 105.753 -1.944 . . . . 4.21 105.753 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.4 t -76.69 -20.77 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.161 0.505 . . . . 0.23000000000000001 109.729 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.69 134.69 21.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.586 -2.005 . . . . 1.8799999999999999 105.586 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -119.17 151.18 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.156 -1.794 . . . . 0.17000000000000001 106.156 175.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -136.12 138.49 27.53 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 107.776 -1.194 . . . . 0.17999999999999999 107.776 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.27 -20.75 32.04 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.981 1.787 . . . . 0.14000000000000001 111.594 164.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -171.72 117.2 0.4 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.132 -1.803 . . . . 1.78 106.132 -170.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -148.61 66.81 1.06 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 103.769 -2.678 . . . . 1.74 103.769 173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.158 -1.877 . . . . 1.96 106.364 -175.475 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 106.011 -1.848 . . . . 2.8500000000000001 106.011 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.99 -18.71 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.122 0.487 . . . . 0.23000000000000001 109.814 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.6 135.01 20.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.403 -2.073 . . . . 1.8799999999999999 105.403 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.23 152.69 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.957 -1.868 . . . . 0.16 105.957 174.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.99 139.41 26.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.428 -1.323 . . . . 0.17000000000000001 107.428 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 -20.68 31.12 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.919 1.746 . . . . 0.16 111.558 164.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -171.92 117.45 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.147 -1.797 . . . . 1.71 106.147 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -151.34 63.7 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 103.666 -2.716 . . . . 1.6599999999999999 103.666 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.183 0 CA-C-O 116.034 -1.936 . . . . 1.99 105.965 -175.026 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 107.435 -1.32 . . . . 3.0800000000000001 107.435 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.23 -18.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 123.671 0.788 . . . . 0.23000000000000001 109.826 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.13 132.42 16.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.944 -1.873 . . . . 1.8999999999999999 105.944 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.52 151.62 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 106.47 -1.678 . . . . 0.19 106.47 175.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -136.35 139.32 29.38 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.574 -1.269 . . . . 0.20000000000000001 107.574 166.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.26 -20.08 32.95 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.883 1.722 . . . . 0.19 111.647 164.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -171.81 119.55 0.44 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.103 -1.814 . . . . 1.9099999999999999 106.103 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -153.46 61.79 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.226 -2.509 . . . . 1.6899999999999999 104.226 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.269 -1.752 . . . . 1.45 106.269 -170.614 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.776 -1.194 . . . . 3.3599999999999999 107.776 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.97 -25.19 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 123.015 0.526 . . . . 0.26000000000000001 110.463 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -146.44 117.83 7.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.193 -1.41 . . . . 1.8200000000000001 107.193 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -101.54 152.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.545 -1.65 . . . . 0.17000000000000001 106.545 175.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -138.22 138.59 23.26 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.446 -1.316 . . . . 0.20000000000000001 107.446 165.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.63 -19.39 32.05 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.773 1.649 . . . . 0.17999999999999999 111.647 165.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -172.14 119.22 0.41 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.092 -1.818 . . . . 1.77 106.092 -169.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -149.75 57.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.761 -2.681 . . . . 1.79 103.761 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.246 0.895 0 N-CA-C 106.573 -1.64 . . . . 1.4199999999999999 106.573 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 106.471 -1.677 . . . . 2.9900000000000002 106.471 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.82 -23.23 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.077 0.465 . . . . 0.22 110.02 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -143.81 132.7 22.69 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.148 -1.797 . . . . 1.8700000000000001 106.148 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -117.04 151.4 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.20000000000000001 106.215 175.17 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.59 139.01 25.82 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.482 -1.303 . . . . 0.17999999999999999 107.482 166.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.2 -20.03 33.29 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.874 1.716 . . . . 0.19 111.578 163.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -171.24 118.47 0.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.424 -1.695 . . . . 1.97 106.424 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -150.37 63.29 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.2 -2.889 . . . . 1.8300000000000001 103.2 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.247 0.933 0 N-CA-C 106.447 -1.686 . . . . 1.4099999999999999 106.447 -174.555 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 . . . . . 0 C--O 1.223 -0.296 0 N-CA-C 108.869 -0.789 . . . . 3.3300000000000001 108.869 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.45 -24.14 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 124.952 1.301 . . . . 0.33000000000000002 110.751 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -145.48 119.04 9.09 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.676 -1.601 . . . . 1.76 106.676 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.53 153.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.418 -1.697 . . . . 0.28000000000000003 106.418 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -138.46 140.25 27.47 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.045 -1.465 . . . . 0.29999999999999999 107.045 165.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.05 -20.96 32.8 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.559 1.506 . . . . 0.23000000000000001 111.325 164.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -170.95 115.71 0.44 Allowed 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.738 -1.579 . . . . 2.1499999999999999 106.738 -167.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -153.52 35.98 0.46 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.671 -1.603 . . . . 2.1200000000000001 106.671 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 115.891 -2.004 . . . . 3.25 107.186 -175.578 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.01 -24.77 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.473 0.579 . . . . 0.0 110.009 172.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.61 123.16 11.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -107.27 150.82 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.076 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -136.55 141.09 34.27 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 164.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.39 -21.48 30.49 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.283 1.989 . . . . 0.0 111.641 163.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -170.23 122.61 0.67 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 -167.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -153.61 59.7 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.064 -168.474 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.064 -0.717 . . . . 3.0499999999999998 109.064 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -144.52 118.56 9.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.613 -1.625 . . . . 3.8300000000000001 106.613 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.1 -24.87 28.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.121 0.568 . . . . 0.25 110.14 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -146.17 121.82 10.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.76 -1.57 . . . . 1.6899999999999999 106.76 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -105.77 152.9 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.619 -1.623 . . . . 0.20000000000000001 106.619 175.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -137.85 139.34 26.15 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.803 -1.184 . . . . 0.20000000000000001 107.803 165.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 -20.52 30.18 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.888 1.726 . . . . 0.19 111.691 164.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -171.75 117.36 0.4 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.437 -1.69 . . . . 1.9399999999999999 106.437 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.53 58.75 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 103.711 -2.699 . . . . 1.6799999999999999 103.711 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 C--O 1.247 0.928 0 N-CA-C 106.422 -1.695 . . . . 1.4099999999999999 106.422 -177.077 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.157 -1.053 . . . . 3.6699999999999999 108.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -125.97 135.68 52.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.157 -1.053 . . . . 3.6699999999999999 108.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -125.97 135.68 52.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.047 -0.723 . . . . 4.8799999999999999 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -141.99 128.0 19.55 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.067 -1.457 . . . . 3.5899999999999999 107.067 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.78 -25.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 110.134 -0.321 . . . . 0.29999999999999999 110.134 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -144.83 120.95 10.78 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.039 -1.097 . . . . 1.8799999999999999 108.039 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.85 151.93 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.475 -1.676 . . . . 0.17999999999999999 106.475 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -138.36 142.09 33.82 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 107.381 -1.34 . . . . 0.32000000000000001 107.381 164.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.54 -20.81 35.37 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.012 1.808 . . . . 0.19 111.415 163.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -171.72 119.3 0.44 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.025 -1.842 . . . . 1.6899999999999999 106.025 -166.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -151.55 64.97 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.229 -2.878 . . . . 1.79 103.229 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 C--O 1.246 0.896 0 N-CA-C 106.72 -1.585 . . . . 1.4299999999999999 106.72 -171.272 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.964 -0.754 . . . . 3.46 108.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 122.01 9.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.722 -1.584 . . . . 4.0899999999999999 106.722 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.21 -24.98 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 118.422 0.555 . . . . 0.28999999999999998 110.485 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.01 120.13 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.278 -1.749 . . . . 1.8999999999999999 106.278 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.12 154.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.148 -1.797 . . . . 0.19 106.148 176.224 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.71 142.62 32.01 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.191 -1.411 . . . . 0.42999999999999999 107.191 163.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.79 -20.18 30.29 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.095 1.863 . . . . 0.17999999999999999 111.609 163.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -171.89 117.86 0.4 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.743 -1.947 . . . . 1.8799999999999999 105.743 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -149.58 60.79 1.01 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.742 -2.688 . . . . 1.8300000000000001 103.742 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.246 0.919 0 N-CA-C 106.587 -1.634 . . . . 1.4399999999999999 106.587 -172.815 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 t0 . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 121.249 0.547 . . . . 4.54 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -148.45 125.94 11.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.476 -1.39 . . . . 4.3700000000000001 107.491 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.13 -26.21 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.63 0.772 . . . . 0.22 110.534 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.96 121.15 10.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.431 -1.692 . . . . 1.75 106.431 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -103.86 153.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.711 -1.589 . . . . 0.23000000000000001 106.711 176.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.32 139.12 26.85 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 108.055 -1.091 . . . . 0.25 108.055 164.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -21.12 30.9 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.032 1.821 . . . . 0.25 111.54 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -171.07 118.93 0.49 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.086 -1.82 . . . . 1.73 106.086 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.27 58.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 103.629 -2.73 . . . . 1.8 103.629 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 106.922 -1.51 . . . . 1.5700000000000001 106.922 -176.555 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 3.0699999999999998 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -148.65 119.97 7.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.682 -1.229 . . . . 3.3900000000000001 107.682 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.7 -24.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.01 0.924 . . . . 0.25 110.785 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -144.86 118.97 9.42 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.629 -1.619 . . . . 1.8899999999999999 106.629 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -101.79 153.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.751 -1.574 . . . . 0.17999999999999999 106.751 176.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -139.01 138.75 21.62 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.913 -1.143 . . . . 0.17000000000000001 107.913 165.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.33 -20.39 32.19 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.83 1.687 . . . . 0.14000000000000001 111.537 165.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -172.11 119.21 0.41 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.138 -1.801 . . . . 1.76 106.138 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -148.35 59.63 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 103.308 -2.849 . . . . 1.8999999999999999 103.308 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.247 0.964 0 N-CA-C 106.433 -1.692 . . . . 1.47 106.433 -178.03 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 107.724 -1.213 . . . . 4.2300000000000004 107.724 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -138.8 117.24 12.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.521 -1.289 . . . . 3.3300000000000001 107.521 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.33 -27.09 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.314 0.646 . . . . 0.38 109.699 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.16 124.84 13.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.417 -1.327 . . . . 1.73 107.417 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -109.72 152.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.078 1.751 . . . . 0.14999999999999999 106.649 175.197 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -138.53 140.84 29.19 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 107.305 -1.369 . . . . 0.17999999999999999 107.305 164.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.39 -20.77 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.94 1.76 . . . . 0.17000000000000001 111.617 164.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -170.91 117.84 0.48 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.269 -1.752 . . . . 1.78 106.269 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -151.1 65.66 0.9 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 103.337 -2.838 . . . . 1.8700000000000001 103.337 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.253 1.239 0 CA-C-O 115.843 -2.027 . . . . 1.98 106.331 -174.47 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 108.631 -0.878 . . . . 2.7999999999999998 108.631 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.2 131.53 26.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.579 -1.637 . . . . 2.9900000000000002 106.579 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.82 -19.95 13.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.072 0.549 . . . . 0.25 109.87 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -147.66 132.5 18.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.676 -1.972 . . . . 1.8700000000000001 105.676 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -116.9 151.75 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.281 -1.748 . . . . 0.19 106.281 175.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -135.91 137.66 25.82 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.46 -1.311 . . . . 0.19 107.46 166.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.02 -20.14 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.823 1.682 . . . . 0.17999999999999999 111.514 164.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -171.91 118.31 0.41 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.043 -1.836 . . . . 1.97 106.043 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -147.94 64.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 103.219 -2.882 . . . . 1.8100000000000001 103.219 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.343 -1.725 . . . . 1.46 106.343 -175.357 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 108.147 -1.057 . . . . 3.6899999999999999 108.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.65 123.17 12.43 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.741 -1.207 . . . . 3.21 107.741 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.8 -23.34 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 123.585 0.754 . . . . 0.23999999999999999 110.266 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -144.87 128.09 16.73 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.082 -1.822 . . . . 1.74 106.082 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.67 151.99 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.747 -1.575 . . . . 0.26000000000000001 106.747 174.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -136.55 139.12 28.46 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.968 -1.123 . . . . 0.20000000000000001 107.968 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.27 -21.45 31.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.123 1.882 . . . . 0.16 111.472 163.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -170.43 119.85 0.58 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 106.143 -1.799 . . . . 1.77 106.143 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -148.4 64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 102.907 -2.997 . . . . 1.6699999999999999 102.907 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.247 0.959 0 N-CA-C 106.589 -1.634 . . . . 1.3999999999999999 106.589 -173.356 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 t0 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 117.99 -1.005 . . . . 4.1399999999999997 108.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -130.02 119.57 23.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 120.004 1.274 . . . . 3.2000000000000002 108.249 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.03 -26.25 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 123.867 0.867 . . . . 0.46999999999999997 109.493 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -144.58 133.6 22.7 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.118 -1.808 . . . . 1.78 106.118 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.2 152.42 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.294 -1.743 . . . . 0.17999999999999999 106.294 175.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -136.77 137.62 23.98 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.199 -1.408 . . . . 0.28999999999999998 107.199 167.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.02 -20.33 33.76 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.604 1.536 . . . . 0.23999999999999999 111.436 164.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -171.77 118.8 0.43 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.159 -1.793 . . . . 1.75 106.159 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.56 63.9 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 103.302 -2.851 . . . . 1.9199999999999999 103.302 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.032 -1.937 . . . . 1.96 106.267 -175.659 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.775 -0.454 . . . . 3.75 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -134.15 120.35 19.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.285 -1.376 . . . . 3.5600000000000001 107.285 -175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.47 -26.56 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 122.887 0.475 . . . . 0.25 110.682 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -144.54 116.05 8.11 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.718 -1.215 . . . . 1.8200000000000001 107.718 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -98.02 155.42 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 106.025 -1.842 . . . . 0.23999999999999999 106.025 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -140.02 140.04 22.96 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 107.072 -1.455 . . . . 0.20000000000000001 107.072 164.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.43 -21.08 35.54 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.73 1.62 . . . . 0.22 111.368 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -171.48 120.14 0.48 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.734 -1.95 . . . . 1.74 105.734 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -147.14 63.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.877 -3.009 . . . . 1.6699999999999999 102.877 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.294 -1.813 . . . . 2.0099999999999998 106.726 -175.545 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 108.538 -0.912 . . . . 3.0800000000000001 108.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -140.24 130.12 24.64 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.535 -1.654 . . . . 4.2300000000000004 106.535 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.31 -18.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.962 0.505 . . . . 0.20999999999999999 110.169 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.18 125.6 11.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.474 -1.676 . . . . 1.78 106.474 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -107.78 152.5 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.187 -1.783 . . . . 0.20999999999999999 106.187 173.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.42 138.7 25.46 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.19 -19.49 34.02 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.717 1.612 . . . . 0.16 111.58 164.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -172.61 118.31 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.036 -1.839 . . . . 1.79 106.036 -169.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -148.23 63.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 103.348 -2.834 . . . . 1.6499999999999999 103.348 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.246 0.914 0 N-CA-C 106.418 -1.697 . . . . 1.4199999999999999 106.418 -177.485 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.792 0.806 . . . . 4.21 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -139.73 123.09 17.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.597 -1.261 . . . . 4.7800000000000002 107.597 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -73.23 -22.79 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.605 1.162 . . . . 0.39000000000000001 109.538 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -145.88 132.76 20.14 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.914 -2.254 . . . . 1.78 104.914 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -119.12 152.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 105.905 -1.887 . . . . 0.25 105.905 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -136.1 138.69 28.1 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.625 -1.25 . . . . 0.19 107.625 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.51 -20.43 31.31 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.007 1.804 . . . . 0.17999999999999999 111.53 164.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -171.25 119.07 0.48 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.296 -1.742 . . . . 2.0299999999999998 106.296 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.6 58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.774 -2.676 . . . . 1.8 103.774 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.253 1.275 0 CA-C-O 115.869 -2.015 . . . . 1.8899999999999999 106.399 -175.481 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 2.7799999999999998 108.997 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.09 132.7 28.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.753 -1.944 . . . . 4.21 105.753 166.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.4 t -76.69 -20.77 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.161 0.505 . . . . 0.23000000000000001 109.729 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.69 134.69 21.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.586 -2.005 . . . . 1.8799999999999999 105.586 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -119.17 151.18 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.156 -1.794 . . . . 0.17000000000000001 106.156 175.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -136.12 138.49 27.53 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 107.776 -1.194 . . . . 0.17999999999999999 107.776 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.27 -20.75 32.04 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.981 1.787 . . . . 0.14000000000000001 111.594 164.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -171.72 117.2 0.4 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.132 -1.803 . . . . 1.78 106.132 -170.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -148.61 66.81 1.06 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 103.769 -2.678 . . . . 1.74 103.769 173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.158 -1.877 . . . . 1.96 106.364 -175.475 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.216 -0.661 . . . . 3.2200000000000002 109.216 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.35 131.09 27.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.011 -1.848 . . . . 2.8500000000000001 106.011 169.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.99 -18.71 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.122 0.487 . . . . 0.23000000000000001 109.814 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.6 135.01 20.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.403 -2.073 . . . . 1.8799999999999999 105.403 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.23 152.69 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.957 -1.868 . . . . 0.16 105.957 174.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.99 139.41 26.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.428 -1.323 . . . . 0.17000000000000001 107.428 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 -20.68 31.12 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.919 1.746 . . . . 0.16 111.558 164.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -171.92 117.45 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.147 -1.797 . . . . 1.71 106.147 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -151.34 63.7 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 103.666 -2.716 . . . . 1.6599999999999999 103.666 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.183 0 CA-C-O 116.034 -1.936 . . . . 1.99 105.965 -175.026 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.174 -0.676 . . . . 3.2999999999999998 109.174 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -137.48 136.71 37.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.435 -1.32 . . . . 3.0800000000000001 107.435 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.23 -18.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 123.671 0.788 . . . . 0.23000000000000001 109.826 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.13 132.42 16.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.944 -1.873 . . . . 1.8999999999999999 105.944 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.52 151.62 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 106.47 -1.678 . . . . 0.19 106.47 175.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -136.35 139.32 29.38 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.574 -1.269 . . . . 0.20000000000000001 107.574 166.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.26 -20.08 32.95 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.883 1.722 . . . . 0.19 111.647 164.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -171.81 119.55 0.44 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.103 -1.814 . . . . 1.9099999999999999 106.103 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -153.46 61.79 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.226 -2.509 . . . . 1.6899999999999999 104.226 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.269 -1.752 . . . . 1.45 106.269 -170.614 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 108.365 -0.976 . . . . 3.8399999999999999 108.365 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 121.11 18.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.776 -1.194 . . . . 3.3599999999999999 107.776 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.97 -25.19 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 123.015 0.526 . . . . 0.26000000000000001 110.463 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -146.44 117.83 7.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.193 -1.41 . . . . 1.8200000000000001 107.193 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -101.54 152.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.545 -1.65 . . . . 0.17000000000000001 106.545 175.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -138.22 138.59 23.26 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.446 -1.316 . . . . 0.20000000000000001 107.446 165.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.63 -19.39 32.05 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.773 1.649 . . . . 0.17999999999999999 111.647 165.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -172.14 119.22 0.41 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.092 -1.818 . . . . 1.77 106.092 -169.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -149.75 57.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.761 -2.681 . . . . 1.79 103.761 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.246 0.895 0 N-CA-C 106.573 -1.64 . . . . 1.4199999999999999 106.573 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.164 -0.68 . . . . 3.3399999999999999 109.164 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -142.96 124.37 14.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.471 -1.677 . . . . 2.9900000000000002 106.471 175.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.82 -23.23 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.077 0.465 . . . . 0.22 110.02 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -143.81 132.7 22.69 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.148 -1.797 . . . . 1.8700000000000001 106.148 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -117.04 151.4 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.20000000000000001 106.215 175.17 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.59 139.01 25.82 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.482 -1.303 . . . . 0.17999999999999999 107.482 166.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.2 -20.03 33.29 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.874 1.716 . . . . 0.19 111.578 163.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -171.24 118.47 0.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.424 -1.695 . . . . 1.97 106.424 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -150.37 63.29 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.2 -2.889 . . . . 1.8300000000000001 103.2 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.247 0.933 0 N-CA-C 106.447 -1.686 . . . . 1.4099999999999999 106.447 -174.555 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.4 t0 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 117.51 -1.233 . . . . 4.2999999999999998 107.943 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 -135.55 116.21 13.89 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 120.671 1.578 . . . . 3.3300000000000001 108.869 -172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.45 -24.14 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 124.952 1.301 . . . . 0.33000000000000002 110.751 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -145.48 119.04 9.09 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.676 -1.601 . . . . 1.76 106.676 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.53 153.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.418 -1.697 . . . . 0.28000000000000003 106.418 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -138.46 140.25 27.47 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.045 -1.465 . . . . 0.29999999999999999 107.045 165.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.05 -20.96 32.8 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.559 1.506 . . . . 0.23000000000000001 111.325 164.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -170.95 115.71 0.44 Allowed 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.738 -1.579 . . . . 2.1499999999999999 106.738 -167.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -153.52 35.98 0.46 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.671 -1.603 . . . . 2.1200000000000001 106.671 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 115.891 -2.004 . . . . 3.25 107.186 -175.578 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.13 129.72 18.0 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 172.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.01 -24.77 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.473 0.579 . . . . 0.0 110.009 172.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.61 123.16 11.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -107.27 150.82 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.076 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -136.55 141.09 34.27 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 164.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.39 -21.48 30.49 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.283 1.989 . . . . 0.0 111.641 163.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -170.23 122.61 0.67 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 -167.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -153.61 59.7 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.064 -168.474 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 106.613 -1.625 . . . . 3.8300000000000001 106.613 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.1 -24.87 28.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.121 0.568 . . . . 0.25 110.14 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -146.17 121.82 10.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.76 -1.57 . . . . 1.6899999999999999 106.76 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -105.77 152.9 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.619 -1.623 . . . . 0.20000000000000001 106.619 175.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -137.85 139.34 26.15 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.803 -1.184 . . . . 0.20000000000000001 107.803 165.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 -20.52 30.18 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.888 1.726 . . . . 0.19 111.691 164.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -171.75 117.36 0.4 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.437 -1.69 . . . . 1.9399999999999999 106.437 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.53 58.75 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 103.711 -2.699 . . . . 1.6799999999999999 103.711 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 C--O 1.247 0.928 0 N-CA-C 106.422 -1.695 . . . . 1.4099999999999999 106.422 -177.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 107.067 -1.457 . . . . 3.5899999999999999 107.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.78 -25.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 110.134 -0.321 . . . . 0.29999999999999999 110.134 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -144.83 120.95 10.78 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.039 -1.097 . . . . 1.8799999999999999 108.039 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.85 151.93 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.475 -1.676 . . . . 0.17999999999999999 106.475 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -138.36 142.09 33.82 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 107.381 -1.34 . . . . 0.32000000000000001 107.381 164.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.54 -20.81 35.37 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.012 1.808 . . . . 0.19 111.415 163.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -171.72 119.3 0.44 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.025 -1.842 . . . . 1.6899999999999999 106.025 -166.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -151.55 64.97 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.229 -2.878 . . . . 1.79 103.229 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 C--O 1.246 0.896 0 N-CA-C 106.72 -1.585 . . . . 1.4299999999999999 106.72 -171.272 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 106.722 -1.584 . . . . 4.0899999999999999 106.722 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.21 -24.98 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 118.422 0.555 . . . . 0.28999999999999998 110.485 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.01 120.13 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.278 -1.749 . . . . 1.8999999999999999 106.278 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.12 154.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.148 -1.797 . . . . 0.19 106.148 176.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.71 142.62 32.01 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.191 -1.411 . . . . 0.42999999999999999 107.191 163.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.79 -20.18 30.29 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.095 1.863 . . . . 0.17999999999999999 111.609 163.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -171.89 117.86 0.4 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.743 -1.947 . . . . 1.8799999999999999 105.743 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -149.58 60.79 1.01 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.742 -2.688 . . . . 1.8300000000000001 103.742 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.246 0.919 0 N-CA-C 106.587 -1.634 . . . . 1.4399999999999999 106.587 -172.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 107.491 -1.299 . . . . 4.3700000000000001 107.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.13 -26.21 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.63 0.772 . . . . 0.22 110.534 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.96 121.15 10.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.431 -1.692 . . . . 1.75 106.431 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -103.86 153.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.711 -1.589 . . . . 0.23000000000000001 106.711 176.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.32 139.12 26.85 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 108.055 -1.091 . . . . 0.25 108.055 164.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -21.12 30.9 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.032 1.821 . . . . 0.25 111.54 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -171.07 118.93 0.49 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.086 -1.82 . . . . 1.73 106.086 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.27 58.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 103.629 -2.73 . . . . 1.8 103.629 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 106.922 -1.51 . . . . 1.5700000000000001 106.922 -176.555 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 107.682 -1.229 . . . . 3.3900000000000001 107.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.7 -24.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.01 0.924 . . . . 0.25 110.785 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -144.86 118.97 9.42 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.629 -1.619 . . . . 1.8899999999999999 106.629 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -101.79 153.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.751 -1.574 . . . . 0.17999999999999999 106.751 176.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -139.01 138.75 21.62 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.913 -1.143 . . . . 0.17000000000000001 107.913 165.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.33 -20.39 32.19 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.83 1.687 . . . . 0.14000000000000001 111.537 165.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -172.11 119.21 0.41 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.138 -1.801 . . . . 1.76 106.138 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -148.35 59.63 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 103.308 -2.849 . . . . 1.8999999999999999 103.308 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.247 0.964 0 N-CA-C 106.433 -1.692 . . . . 1.47 106.433 -178.03 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 107.521 -1.289 . . . . 3.3300000000000001 107.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.33 -27.09 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.314 0.646 . . . . 0.38 109.699 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.16 124.84 13.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.417 -1.327 . . . . 1.73 107.417 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -109.72 152.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.078 1.751 . . . . 0.14999999999999999 106.649 175.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -138.53 140.84 29.19 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 107.305 -1.369 . . . . 0.17999999999999999 107.305 164.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.39 -20.77 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.94 1.76 . . . . 0.17000000000000001 111.617 164.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -170.91 117.84 0.48 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.269 -1.752 . . . . 1.78 106.269 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -151.1 65.66 0.9 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 103.337 -2.838 . . . . 1.8700000000000001 103.337 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.253 1.239 0 CA-C-O 115.843 -2.027 . . . . 1.98 106.331 -174.47 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 106.579 -1.637 . . . . 2.9900000000000002 106.579 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.82 -19.95 13.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.072 0.549 . . . . 0.25 109.87 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -147.66 132.5 18.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.676 -1.972 . . . . 1.8700000000000001 105.676 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -116.9 151.75 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.281 -1.748 . . . . 0.19 106.281 175.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -135.91 137.66 25.82 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.46 -1.311 . . . . 0.19 107.46 166.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.02 -20.14 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.823 1.682 . . . . 0.17999999999999999 111.514 164.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -171.91 118.31 0.41 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.043 -1.836 . . . . 1.97 106.043 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -147.94 64.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 103.219 -2.882 . . . . 1.8100000000000001 103.219 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.343 -1.725 . . . . 1.46 106.343 -175.357 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 107.741 -1.207 . . . . 3.21 107.741 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.8 -23.34 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 123.585 0.754 . . . . 0.23999999999999999 110.266 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -144.87 128.09 16.73 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.082 -1.822 . . . . 1.74 106.082 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.67 151.99 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.747 -1.575 . . . . 0.26000000000000001 106.747 174.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -136.55 139.12 28.46 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.968 -1.123 . . . . 0.20000000000000001 107.968 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.27 -21.45 31.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.123 1.882 . . . . 0.16 111.472 163.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -170.43 119.85 0.58 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 106.143 -1.799 . . . . 1.77 106.143 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -148.4 64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 102.907 -2.997 . . . . 1.6699999999999999 102.907 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.247 0.959 0 N-CA-C 106.589 -1.634 . . . . 1.3999999999999999 106.589 -173.356 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 . . . . . 0 C--O 1.224 -0.247 0 N-CA-C 108.249 -1.019 . . . . 3.2000000000000002 108.249 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.03 -26.25 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 123.867 0.867 . . . . 0.46999999999999997 109.493 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -144.58 133.6 22.7 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.118 -1.808 . . . . 1.78 106.118 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.2 152.42 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.294 -1.743 . . . . 0.17999999999999999 106.294 175.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -136.77 137.62 23.98 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.199 -1.408 . . . . 0.28999999999999998 107.199 167.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.02 -20.33 33.76 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.604 1.536 . . . . 0.23999999999999999 111.436 164.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -171.77 118.8 0.43 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.159 -1.793 . . . . 1.75 106.159 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.56 63.9 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 103.302 -2.851 . . . . 1.9199999999999999 103.302 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.032 -1.937 . . . . 1.96 106.267 -175.659 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 107.285 -1.376 . . . . 3.5600000000000001 107.285 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.47 -26.56 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 122.887 0.475 . . . . 0.25 110.682 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -144.54 116.05 8.11 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.718 -1.215 . . . . 1.8200000000000001 107.718 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -98.02 155.42 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 106.025 -1.842 . . . . 0.23999999999999999 106.025 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -140.02 140.04 22.96 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 107.072 -1.455 . . . . 0.20000000000000001 107.072 164.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.43 -21.08 35.54 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.73 1.62 . . . . 0.22 111.368 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -171.48 120.14 0.48 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.734 -1.95 . . . . 1.74 105.734 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -147.14 63.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.877 -3.009 . . . . 1.6699999999999999 102.877 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.294 -1.813 . . . . 2.0099999999999998 106.726 -175.545 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 106.535 -1.654 . . . . 4.2300000000000004 106.535 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.31 -18.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.962 0.505 . . . . 0.20999999999999999 110.169 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.18 125.6 11.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.474 -1.676 . . . . 1.78 106.474 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -107.78 152.5 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.187 -1.783 . . . . 0.20999999999999999 106.187 173.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.42 138.7 25.46 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.19 -19.49 34.02 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.717 1.612 . . . . 0.16 111.58 164.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -172.61 118.31 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.036 -1.839 . . . . 1.79 106.036 -169.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -148.23 63.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 103.348 -2.834 . . . . 1.6499999999999999 103.348 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.246 0.914 0 N-CA-C 106.418 -1.697 . . . . 1.4199999999999999 106.418 -177.485 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 107.597 -1.261 . . . . 4.7800000000000002 107.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -73.23 -22.79 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.605 1.162 . . . . 0.39000000000000001 109.538 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -145.88 132.76 20.14 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.914 -2.254 . . . . 1.78 104.914 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -119.12 152.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 105.905 -1.887 . . . . 0.25 105.905 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -136.1 138.69 28.1 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.625 -1.25 . . . . 0.19 107.625 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.51 -20.43 31.31 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.007 1.804 . . . . 0.17999999999999999 111.53 164.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -171.25 119.07 0.48 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.296 -1.742 . . . . 2.0299999999999998 106.296 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.6 58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.774 -2.676 . . . . 1.8 103.774 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.253 1.275 0 CA-C-O 115.869 -2.015 . . . . 1.8899999999999999 106.399 -175.481 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 105.753 -1.944 . . . . 4.21 105.753 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.4 t -76.69 -20.77 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.161 0.505 . . . . 0.23000000000000001 109.729 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.69 134.69 21.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.586 -2.005 . . . . 1.8799999999999999 105.586 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -119.17 151.18 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.156 -1.794 . . . . 0.17000000000000001 106.156 175.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -136.12 138.49 27.53 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 107.776 -1.194 . . . . 0.17999999999999999 107.776 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.27 -20.75 32.04 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.981 1.787 . . . . 0.14000000000000001 111.594 164.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -171.72 117.2 0.4 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.132 -1.803 . . . . 1.78 106.132 -170.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -148.61 66.81 1.06 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 103.769 -2.678 . . . . 1.74 103.769 173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.158 -1.877 . . . . 1.96 106.364 -175.475 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 106.011 -1.848 . . . . 2.8500000000000001 106.011 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.99 -18.71 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.122 0.487 . . . . 0.23000000000000001 109.814 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.6 135.01 20.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.403 -2.073 . . . . 1.8799999999999999 105.403 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.23 152.69 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.957 -1.868 . . . . 0.16 105.957 174.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.99 139.41 26.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.428 -1.323 . . . . 0.17000000000000001 107.428 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 -20.68 31.12 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.919 1.746 . . . . 0.16 111.558 164.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -171.92 117.45 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.147 -1.797 . . . . 1.71 106.147 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -151.34 63.7 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 103.666 -2.716 . . . . 1.6599999999999999 103.666 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.183 0 CA-C-O 116.034 -1.936 . . . . 1.99 105.965 -175.026 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 107.435 -1.32 . . . . 3.0800000000000001 107.435 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.23 -18.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 123.671 0.788 . . . . 0.23000000000000001 109.826 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.13 132.42 16.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.944 -1.873 . . . . 1.8999999999999999 105.944 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.52 151.62 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 106.47 -1.678 . . . . 0.19 106.47 175.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -136.35 139.32 29.38 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.574 -1.269 . . . . 0.20000000000000001 107.574 166.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.26 -20.08 32.95 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.883 1.722 . . . . 0.19 111.647 164.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -171.81 119.55 0.44 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.103 -1.814 . . . . 1.9099999999999999 106.103 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -153.46 61.79 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.226 -2.509 . . . . 1.6899999999999999 104.226 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.269 -1.752 . . . . 1.45 106.269 -170.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.776 -1.194 . . . . 3.3599999999999999 107.776 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.97 -25.19 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 123.015 0.526 . . . . 0.26000000000000001 110.463 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -146.44 117.83 7.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.193 -1.41 . . . . 1.8200000000000001 107.193 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -101.54 152.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.545 -1.65 . . . . 0.17000000000000001 106.545 175.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -138.22 138.59 23.26 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.446 -1.316 . . . . 0.20000000000000001 107.446 165.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.63 -19.39 32.05 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.773 1.649 . . . . 0.17999999999999999 111.647 165.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -172.14 119.22 0.41 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.092 -1.818 . . . . 1.77 106.092 -169.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -149.75 57.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.761 -2.681 . . . . 1.79 103.761 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.246 0.895 0 N-CA-C 106.573 -1.64 . . . . 1.4199999999999999 106.573 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 106.471 -1.677 . . . . 2.9900000000000002 106.471 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.82 -23.23 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.077 0.465 . . . . 0.22 110.02 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -143.81 132.7 22.69 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.148 -1.797 . . . . 1.8700000000000001 106.148 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -117.04 151.4 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.20000000000000001 106.215 175.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.59 139.01 25.82 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.482 -1.303 . . . . 0.17999999999999999 107.482 166.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.2 -20.03 33.29 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.874 1.716 . . . . 0.19 111.578 163.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -171.24 118.47 0.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.424 -1.695 . . . . 1.97 106.424 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -150.37 63.29 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.2 -2.889 . . . . 1.8300000000000001 103.2 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.247 0.933 0 N-CA-C 106.447 -1.686 . . . . 1.4099999999999999 106.447 -174.555 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 . . . . . 0 C--O 1.223 -0.296 0 N-CA-C 108.869 -0.789 . . . . 3.3300000000000001 108.869 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.45 -24.14 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 124.952 1.301 . . . . 0.33000000000000002 110.751 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -145.48 119.04 9.09 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.676 -1.601 . . . . 1.76 106.676 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.53 153.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.418 -1.697 . . . . 0.28000000000000003 106.418 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -138.46 140.25 27.47 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.045 -1.465 . . . . 0.29999999999999999 107.045 165.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.05 -20.96 32.8 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.559 1.506 . . . . 0.23000000000000001 111.325 164.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -170.95 115.71 0.44 Allowed 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.738 -1.579 . . . . 2.1499999999999999 106.738 -167.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -153.52 35.98 0.46 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.671 -1.603 . . . . 2.1200000000000001 106.671 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 115.891 -2.004 . . . . 3.25 107.186 -175.578 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.01 -24.77 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.473 0.579 . . . . 0.0 110.009 172.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.61 123.16 11.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -107.27 150.82 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.076 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -136.55 141.09 34.27 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 164.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.39 -21.48 30.49 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.283 1.989 . . . . 0.0 111.641 163.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -170.23 122.61 0.67 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 -167.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.61 59.7 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.064 -168.474 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.064 -0.717 . . . . 3.0499999999999998 109.064 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -144.52 118.56 9.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.613 -1.625 . . . . 3.8300000000000001 106.613 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.1 -24.87 28.6 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.121 0.568 . . . . 0.25 110.14 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -146.17 121.82 10.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.76 -1.57 . . . . 1.6899999999999999 106.76 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -105.77 152.9 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.619 -1.623 . . . . 0.20000000000000001 106.619 175.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -137.85 139.34 26.15 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.803 -1.184 . . . . 0.20000000000000001 107.803 165.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 -20.52 30.18 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.888 1.726 . . . . 0.19 111.691 164.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -171.75 117.36 0.4 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.437 -1.69 . . . . 1.9399999999999999 106.437 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.53 58.75 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 103.711 -2.699 . . . . 1.6799999999999999 103.711 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 C--O 1.247 0.928 0 N-CA-C 106.422 -1.695 . . . . 1.4099999999999999 106.422 -177.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.157 -1.053 . . . . 3.6699999999999999 108.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -125.97 135.68 52.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 169.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.157 -1.053 . . . . 3.6699999999999999 108.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -125.97 135.68 52.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.763 -1.569 . . . . 5.9500000000000002 106.763 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.75 -21.53 13.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 123.29 0.636 . . . . 0.25 109.946 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -147.45 132.35 18.08 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.282 -1.747 . . . . 1.9399999999999999 106.282 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -117.47 153.25 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.293 -1.743 . . . . 0.20999999999999999 106.293 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -136.78 137.71 24.22 Favored Pre-proline 0 N--CA 1.442 -0.848 0 N-CA-C 107.461 -1.311 . . . . 0.23999999999999999 107.461 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 -20.93 34.09 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.683 1.588 . . . . 0.20999999999999999 111.478 164.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -171.58 118.3 0.43 Allowed 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.279 -1.749 . . . . 1.9199999999999999 106.279 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -146.96 56.59 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 103.735 -2.691 . . . . 1.8200000000000001 103.735 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 116.87 -1.538 . . . . 1.48 107.116 178.232 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.047 -0.723 . . . . 4.8799999999999999 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -141.99 128.0 19.55 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.067 -1.457 . . . . 3.5899999999999999 107.067 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.78 -25.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 N-CA-C 110.134 -0.321 . . . . 0.29999999999999999 110.134 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -144.83 120.95 10.78 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.039 -1.097 . . . . 1.8799999999999999 108.039 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.85 151.93 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.475 -1.676 . . . . 0.17999999999999999 106.475 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -138.36 142.09 33.82 Favored Pre-proline 0 N--CA 1.44 -0.938 0 N-CA-C 107.381 -1.34 . . . . 0.32000000000000001 107.381 164.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.54 -20.81 35.37 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.012 1.808 . . . . 0.19 111.415 163.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -171.72 119.3 0.44 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.025 -1.842 . . . . 1.6899999999999999 106.025 -166.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -151.55 64.97 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.229 -2.878 . . . . 1.79 103.229 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 C--O 1.246 0.896 0 N-CA-C 106.72 -1.585 . . . . 1.4299999999999999 106.72 -171.272 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.964 -0.754 . . . . 3.46 108.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 122.01 9.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.722 -1.584 . . . . 4.0899999999999999 106.722 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.21 -24.98 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 118.422 0.555 . . . . 0.28999999999999998 110.485 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.01 120.13 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.278 -1.749 . . . . 1.8999999999999999 106.278 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.12 154.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.148 -1.797 . . . . 0.19 106.148 176.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.71 142.62 32.01 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 107.191 -1.411 . . . . 0.42999999999999999 107.191 163.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.79 -20.18 30.29 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.095 1.863 . . . . 0.17999999999999999 111.609 163.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -171.89 117.86 0.4 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.743 -1.947 . . . . 1.8799999999999999 105.743 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -149.58 60.79 1.01 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.742 -2.688 . . . . 1.8300000000000001 103.742 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.246 0.919 0 N-CA-C 106.587 -1.634 . . . . 1.4399999999999999 106.587 -172.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 t0 . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 121.249 0.547 . . . . 4.54 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -148.45 125.94 11.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.476 -1.39 . . . . 4.3700000000000001 107.491 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.13 -26.21 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.63 0.772 . . . . 0.22 110.534 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.96 121.15 10.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.431 -1.692 . . . . 1.75 106.431 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -103.86 153.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.711 -1.589 . . . . 0.23000000000000001 106.711 176.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.32 139.12 26.85 Favored Pre-proline 0 N--CA 1.441 -0.885 0 N-CA-C 108.055 -1.091 . . . . 0.25 108.055 164.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -21.12 30.9 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.032 1.821 . . . . 0.25 111.54 164.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -171.07 118.93 0.49 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.086 -1.82 . . . . 1.73 106.086 -169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.27 58.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 103.629 -2.73 . . . . 1.8 103.629 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 106.922 -1.51 . . . . 1.5700000000000001 106.922 -176.555 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 3.0699999999999998 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -148.65 119.97 7.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.682 -1.229 . . . . 3.3900000000000001 107.682 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.7 -24.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.01 0.924 . . . . 0.25 110.785 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -144.86 118.97 9.42 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.629 -1.619 . . . . 1.8899999999999999 106.629 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -101.79 153.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.751 -1.574 . . . . 0.17999999999999999 106.751 176.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -139.01 138.75 21.62 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.913 -1.143 . . . . 0.17000000000000001 107.913 165.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.33 -20.39 32.19 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.83 1.687 . . . . 0.14000000000000001 111.537 165.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -172.11 119.21 0.41 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.138 -1.801 . . . . 1.76 106.138 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -148.35 59.63 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 103.308 -2.849 . . . . 1.8999999999999999 103.308 175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--O 1.247 0.964 0 N-CA-C 106.433 -1.692 . . . . 1.47 106.433 -178.03 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 107.724 -1.213 . . . . 4.2300000000000004 107.724 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -138.8 117.24 12.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.521 -1.289 . . . . 3.3300000000000001 107.521 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.33 -27.09 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.314 0.646 . . . . 0.38 109.699 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.16 124.84 13.28 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.417 -1.327 . . . . 1.73 107.417 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -109.72 152.99 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 126.078 1.751 . . . . 0.14999999999999999 106.649 175.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -138.53 140.84 29.19 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 107.305 -1.369 . . . . 0.17999999999999999 107.305 164.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.39 -20.77 31.43 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.94 1.76 . . . . 0.17000000000000001 111.617 164.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -170.91 117.84 0.48 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.269 -1.752 . . . . 1.78 106.269 -169.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -151.1 65.66 0.9 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 103.337 -2.838 . . . . 1.8700000000000001 103.337 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.253 1.239 0 CA-C-O 115.843 -2.027 . . . . 1.98 106.331 -174.47 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 108.631 -0.878 . . . . 2.7999999999999998 108.631 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.2 131.53 26.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.579 -1.637 . . . . 2.9900000000000002 106.579 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.82 -19.95 13.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.072 0.549 . . . . 0.25 109.87 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -147.66 132.5 18.03 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.676 -1.972 . . . . 1.8700000000000001 105.676 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -116.9 151.75 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.281 -1.748 . . . . 0.19 106.281 175.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -135.91 137.66 25.82 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.46 -1.311 . . . . 0.19 107.46 166.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.02 -20.14 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.823 1.682 . . . . 0.17999999999999999 111.514 164.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -171.91 118.31 0.41 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 106.043 -1.836 . . . . 1.97 106.043 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -147.94 64.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 103.219 -2.882 . . . . 1.8100000000000001 103.219 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.343 -1.725 . . . . 1.46 106.343 -175.357 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 108.147 -1.057 . . . . 3.6899999999999999 108.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -144.65 123.17 12.43 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.741 -1.207 . . . . 3.21 107.741 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.8 -23.34 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 C-N-CA 123.585 0.754 . . . . 0.23999999999999999 110.266 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -144.87 128.09 16.73 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 106.082 -1.822 . . . . 1.74 106.082 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -110.67 151.99 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.747 -1.575 . . . . 0.26000000000000001 106.747 174.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -136.55 139.12 28.46 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.968 -1.123 . . . . 0.20000000000000001 107.968 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.27 -21.45 31.1 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.123 1.882 . . . . 0.16 111.472 163.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -170.43 119.85 0.58 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 106.143 -1.799 . . . . 1.77 106.143 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -148.4 64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 102.907 -2.997 . . . . 1.6699999999999999 102.907 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.247 0.959 0 N-CA-C 106.589 -1.634 . . . . 1.3999999999999999 106.589 -173.356 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.1 t0 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 117.99 -1.005 . . . . 4.1399999999999997 108.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -130.02 119.57 23.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 120.004 1.274 . . . . 3.2000000000000002 108.249 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.03 -26.25 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 123.867 0.867 . . . . 0.46999999999999997 109.493 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -144.58 133.6 22.7 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 106.118 -1.808 . . . . 1.78 106.118 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.2 152.42 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.294 -1.743 . . . . 0.17999999999999999 106.294 175.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -136.77 137.62 23.98 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.199 -1.408 . . . . 0.28999999999999998 107.199 167.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.02 -20.33 33.76 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.604 1.536 . . . . 0.23999999999999999 111.436 164.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -171.77 118.8 0.43 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.159 -1.793 . . . . 1.75 106.159 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.56 63.9 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 103.302 -2.851 . . . . 1.9199999999999999 103.302 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.032 -1.937 . . . . 1.96 106.267 -175.659 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.775 -0.454 . . . . 3.75 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -134.15 120.35 19.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.285 -1.376 . . . . 3.5600000000000001 107.285 -175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.47 -26.56 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 C-N-CA 122.887 0.475 . . . . 0.25 110.682 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -144.54 116.05 8.11 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.718 -1.215 . . . . 1.8200000000000001 107.718 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -98.02 155.42 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 106.025 -1.842 . . . . 0.23999999999999999 106.025 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -140.02 140.04 22.96 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 107.072 -1.455 . . . . 0.20000000000000001 107.072 164.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.43 -21.08 35.54 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.73 1.62 . . . . 0.22 111.368 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -171.48 120.14 0.48 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.734 -1.95 . . . . 1.74 105.734 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -147.14 63.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.877 -3.009 . . . . 1.6699999999999999 102.877 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.294 -1.813 . . . . 2.0099999999999998 106.726 -175.545 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 108.538 -0.912 . . . . 3.0800000000000001 108.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -140.24 130.12 24.64 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.535 -1.654 . . . . 4.2300000000000004 106.535 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.31 -18.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 122.962 0.505 . . . . 0.20999999999999999 110.169 173.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.18 125.6 11.63 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.474 -1.676 . . . . 1.78 106.474 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -107.78 152.5 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.187 -1.783 . . . . 0.20999999999999999 106.187 173.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -137.42 138.7 25.46 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.19 -19.49 34.02 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.717 1.612 . . . . 0.16 111.58 164.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -172.61 118.31 0.35 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.036 -1.839 . . . . 1.79 106.036 -169.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -148.23 63.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 103.348 -2.834 . . . . 1.6499999999999999 103.348 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.246 0.914 0 N-CA-C 106.418 -1.697 . . . . 1.4199999999999999 106.418 -177.485 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.792 0.806 . . . . 4.21 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -139.73 123.09 17.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.597 -1.261 . . . . 4.7800000000000002 107.597 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 t -73.23 -22.79 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.605 1.162 . . . . 0.39000000000000001 109.538 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -145.88 132.76 20.14 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.914 -2.254 . . . . 1.78 104.914 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -119.12 152.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 105.905 -1.887 . . . . 0.25 105.905 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -136.1 138.69 28.1 Favored Pre-proline 0 N--CA 1.442 -0.836 0 N-CA-C 107.625 -1.25 . . . . 0.19 107.625 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.51 -20.43 31.31 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.007 1.804 . . . . 0.17999999999999999 111.53 164.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -171.25 119.07 0.48 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.296 -1.742 . . . . 2.0299999999999998 106.296 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -151.6 58.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.774 -2.676 . . . . 1.8 103.774 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--O 1.253 1.275 0 CA-C-O 115.869 -2.015 . . . . 1.8899999999999999 106.399 -175.481 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 2.7799999999999998 108.997 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.09 132.7 28.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.753 -1.944 . . . . 4.21 105.753 166.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.4 t -76.69 -20.77 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.161 0.505 . . . . 0.23000000000000001 109.729 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -146.69 134.69 21.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 105.586 -2.005 . . . . 1.8799999999999999 105.586 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -119.17 151.18 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.156 -1.794 . . . . 0.17000000000000001 106.156 175.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -136.12 138.49 27.53 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 107.776 -1.194 . . . . 0.17999999999999999 107.776 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.27 -20.75 32.04 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.981 1.787 . . . . 0.14000000000000001 111.594 164.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -171.72 117.2 0.4 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.132 -1.803 . . . . 1.78 106.132 -170.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -148.61 66.81 1.06 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 103.769 -2.678 . . . . 1.74 103.769 173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.158 -1.877 . . . . 1.96 106.364 -175.475 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.216 -0.661 . . . . 3.2200000000000002 109.216 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.35 131.09 27.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.011 -1.848 . . . . 2.8500000000000001 106.011 169.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -77.99 -18.71 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.122 0.487 . . . . 0.23000000000000001 109.814 176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.6 135.01 20.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.403 -2.073 . . . . 1.8799999999999999 105.403 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -118.23 152.69 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.957 -1.868 . . . . 0.16 105.957 174.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.99 139.41 26.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.428 -1.323 . . . . 0.17000000000000001 107.428 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 -20.68 31.12 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.919 1.746 . . . . 0.16 111.558 164.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -171.92 117.45 0.39 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.147 -1.797 . . . . 1.71 106.147 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -151.34 63.7 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 103.666 -2.716 . . . . 1.6599999999999999 103.666 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.183 0 CA-C-O 116.034 -1.936 . . . . 1.99 105.965 -175.026 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.174 -0.676 . . . . 3.2999999999999998 109.174 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -137.48 136.71 37.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.435 -1.32 . . . . 3.0800000000000001 107.435 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.23 -18.14 13.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 123.671 0.788 . . . . 0.23000000000000001 109.826 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -149.13 132.42 16.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.944 -1.873 . . . . 1.8999999999999999 105.944 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.52 151.62 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 106.47 -1.678 . . . . 0.19 106.47 175.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -136.35 139.32 29.38 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.574 -1.269 . . . . 0.20000000000000001 107.574 166.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.26 -20.08 32.95 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.883 1.722 . . . . 0.19 111.647 164.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -171.81 119.55 0.44 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 106.103 -1.814 . . . . 1.9099999999999999 106.103 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -153.46 61.79 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.226 -2.509 . . . . 1.6899999999999999 104.226 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--O 1.247 0.932 0 N-CA-C 106.269 -1.752 . . . . 1.45 106.269 -170.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 108.365 -0.976 . . . . 3.8399999999999999 108.365 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 121.11 18.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.776 -1.194 . . . . 3.3599999999999999 107.776 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.97 -25.19 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 123.015 0.526 . . . . 0.26000000000000001 110.463 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -146.44 117.83 7.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.193 -1.41 . . . . 1.8200000000000001 107.193 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -101.54 152.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.545 -1.65 . . . . 0.17000000000000001 106.545 175.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -138.22 138.59 23.26 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 107.446 -1.316 . . . . 0.20000000000000001 107.446 165.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.63 -19.39 32.05 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.773 1.649 . . . . 0.17999999999999999 111.647 165.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -172.14 119.22 0.41 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.092 -1.818 . . . . 1.77 106.092 -169.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -149.75 57.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.761 -2.681 . . . . 1.79 103.761 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.246 0.895 0 N-CA-C 106.573 -1.64 . . . . 1.4199999999999999 106.573 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.164 -0.68 . . . . 3.3399999999999999 109.164 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -142.96 124.37 14.73 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.471 -1.677 . . . . 2.9900000000000002 106.471 175.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.82 -23.23 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.077 0.465 . . . . 0.22 110.02 172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -143.81 132.7 22.69 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 106.148 -1.797 . . . . 1.8700000000000001 106.148 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -117.04 151.4 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.215 -1.772 . . . . 0.20000000000000001 106.215 175.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -137.59 139.01 25.82 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 107.482 -1.303 . . . . 0.17999999999999999 107.482 166.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.2 -20.03 33.29 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.874 1.716 . . . . 0.19 111.578 163.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -171.24 118.47 0.47 Allowed 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.424 -1.695 . . . . 1.97 106.424 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -150.37 63.29 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.2 -2.889 . . . . 1.8300000000000001 103.2 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.247 0.933 0 N-CA-C 106.447 -1.686 . . . . 1.4099999999999999 106.447 -174.555 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.4 t0 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 117.51 -1.233 . . . . 4.2999999999999998 107.943 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 21.1 ttt85 -135.55 116.21 13.89 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 120.671 1.578 . . . . 3.3300000000000001 108.869 -172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.45 -24.14 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 124.952 1.301 . . . . 0.33000000000000002 110.751 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -145.48 119.04 9.09 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.676 -1.601 . . . . 1.76 106.676 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -102.53 153.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.418 -1.697 . . . . 0.28000000000000003 106.418 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -138.46 140.25 27.47 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.045 -1.465 . . . . 0.29999999999999999 107.045 165.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.05 -20.96 32.8 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.559 1.506 . . . . 0.23000000000000001 111.325 164.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -170.95 115.71 0.44 Allowed 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.738 -1.579 . . . . 2.1499999999999999 106.738 -167.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -153.52 35.98 0.46 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.671 -1.603 . . . . 2.1200000000000001 106.671 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 115.891 -2.004 . . . . 3.25 107.186 -175.578 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.13 129.72 18.0 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 172.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.01 -24.77 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 118.473 0.579 . . . . 0.0 110.009 172.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -146.61 123.16 11.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -107.27 150.82 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.076 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -136.55 141.09 34.27 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 164.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.39 -21.48 30.49 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.283 1.989 . . . . 0.0 111.641 163.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -170.23 122.61 0.67 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 -167.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.61 59.7 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.064 -168.474 . . . . . . . . 0 0 . 1 stop_ save_